Max Healthcare Institute share price ends at ₹1,046, down 1.31% on September 24

Key Takeaways 

• Max Healthcare Institute closed at ₹1,046, down ₹13.90 or 1.31%, but finished ₹11 above its ₹1,035 opening price.
• The closing price was above the 50-day and 100-day DMAs, while sitting only ₹6.60 below the 200-day DMA of ₹1,052.60.
• One-month and six-month returns were positive at 4.60% and 9.31%, although one year remained negative at -9.59%.

Max Healthcare Institute share price finished September 24 at ₹1,046, down ₹13.90 or 1.31% from the previous close of ₹1,060. The stock opened lower at ₹1,035, fell to ₹1,029 and later reached ₹1,056. The daily range was ₹27. Despite the decline versus the previous session, the stock closed ₹11 above its opening price.

The final price sat ₹17 above the session low and ₹10 below the high. Volume reached 2,551,282 shares, while market capitalisation stood at ₹101,808 crore. That open-to-close increase made the intraday pattern different from the negative day-on-day percentage change.

Moving averages were clustered close to the closing price. The 50-day DMA stood at ₹1,038.80, leaving Max Healthcare ₹7.20 above it. The 100-day DMA was ₹1,043.10, only ₹2.90 below the close. The 200-day DMA stood at ₹1,052.60, or ₹6.60 above the finish. Just ₹13.80 separated all three averages.

Across 52 weeks, the stock’s low was ₹903 and its high ₹1,222. The ₹1,046 close was ₹143 above the lower marker and ₹176 below the annual high. The full range measured ₹319.

Historical returns were 4.60% for one month, -2.97% for three months, 9.31% for six months and -9.59% for one year. Six months was the strongest displayed period. The difference between that figure and the one-year return was 18.90 percentage points.

The closest moving-average level was the 100-day DMA, only ₹2.90 below the close. The 200-day average was ₹6.60 above, and the 50-day reading ₹7.20 below. Those were unusually tight gaps compared with the ₹27 daily range. The stock also finished above its opening level even though the September 24 day-on-day performance remained negative.